BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28674120)

  • 1. Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma.
    Kalish JM; Doros L; Helman LJ; Hennekam RC; Kuiper RP; Maas SM; Maher ER; Nichols KE; Plon SE; Porter CC; Rednam S; Schultz KAP; States LJ; Tomlinson GE; Zelley K; Druley TE
    Clin Cancer Res; 2017 Jul; 23(13):e115-e122. PubMed ID: 28674120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Wilms tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes: a cost-effective model.
    McNeil DE; Brown M; Ching A; DeBaun MR
    Med Pediatr Oncol; 2001 Oct; 37(4):349-56. PubMed ID: 11568898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Fetoprotein assay on dried blood spot for hepatoblastoma screening in children with overgrowth-cancer predisposition syndromes.
    Mussa A; Pagliardini S; Pagliardini V; Molinatto C; Baldassarre G; Corrias A; Silengo MC; Ferrero GB
    Pediatr Res; 2014 Dec; 76(6):544-8. PubMed ID: 25167201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoblastoma in molecularly defined, congenital diseases.
    Nussbaumer G; Benesch M
    Am J Med Genet A; 2022 Sep; 188(9):2527-2535. PubMed ID: 35478319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between birth defects with neural crest cell origins and pediatric embryonal tumors.
    Wong EC; Lupo PJ; Desrosiers TA; Nichols HB; Smith SM; Poole C; Canfield M; Shumate C; Chambers TM; Schraw JM; Nembhard WN; Yazdy MM; Nestoridi E; Janitz AE; Olshan AF
    Cancer; 2023 Nov; 129(22):3595-3602. PubMed ID: 37432072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lateralized overgrowth as a guiding sign of abdominal neoplasms for pediatric orthopedic surgeons.
    Parada-Avendaño I; Salvador H; García RG; Martorell-Sampol L; Fontecha CG; Torner-Rubies F; Perez-Lopez LM
    Jt Dis Relat Surg; 2023; 34(1):3-8. PubMed ID: 36700257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr.
    Brodeur GM; Nichols KE; Plon SE; Schiffman JD; Malkin D
    Clin Cancer Res; 2017 Jun; 23(11):e1-e5. PubMed ID: 28572261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood.
    Achatz MI; Porter CC; Brugières L; Druker H; Frebourg T; Foulkes WD; Kratz CP; Kuiper RP; Hansford JR; Hernandez HS; Nathanson KL; Kohlmann WK; Doros L; Onel K; Schneider KW; Scollon SR; Tabori U; Tomlinson GE; Evans DGR; Plon SE
    Clin Cancer Res; 2017 Jul; 23(13):e107-e114. PubMed ID: 28674119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms tumour surveillance in at-risk children: Literature review and recommendations from the SIOP-Europe Host Genome Working Group and SIOP Renal Tumour Study Group.
    Hol JA; Jewell R; Chowdhury T; Duncan C; Nakata K; Oue T; Gauthier-Villars M; Littooij AS; Kaneko Y; Graf N; Bourdeaut F; van den Heuvel-Eibrink MM; Pritchard-Jones K; Maher ER; Kratz CP; Jongmans MCJ
    Eur J Cancer; 2021 Aug; 153():51-63. PubMed ID: 34134020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low risk of embryonic and other cancers in PIK3CA-related overgrowth spectrum: Impact on screening recommendations.
    Faivre L; Crépin JC; Réda M; Nambot S; Carmignac V; Abadie C; Mirault T; Faure-Conter C; Mazereeuw-Hautier J; Maza A; Puzenat E; Collonge-Rame MA; Bursztejn AC; Philippe C; Thauvin-Robinet C; Chevarin M; Abasq-Thomas C; Amiel J; Arpin S; Barbarot S; Baujat G; Bessis D; Bourrat E; Boute O; Chassaing N; Coubes C; Demeer B; Edery P; El Chehadeh S; Goldenberg A; Hadj-Rabia S; Haye D; Isidor B; Jacquemont ML; Van Kien PK; Lacombe D; Lehalle D; Lambert L; Martin L; Maruani A; Morice-Picard F; Petit F; Phan A; Pinson L; Rossi M; Touraine R; Vanlerberghe C; Vincent M; Vincent-Delorme C; Whalen S; Willems M; Marle N; Verkarre V; Devalland C; Devouassoux-Shisheboran M; Abad M; Rioux-Leclercq N; Bonniaud B; Duffourd Y; Martel J; Binquet C; Kuentz P; Vabres P
    Clin Genet; 2023 Nov; 104(5):554-563. PubMed ID: 37580112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Counselor Recommendations for Cancer Predisposition Evaluation and Surveillance in the Pediatric Oncology Patient.
    Druker H; Zelley K; McGee RB; Scollon SR; Kohlmann WK; Schneider KA; Wolfe Schneider K
    Clin Cancer Res; 2017 Jul; 23(13):e91-e97. PubMed ID: 28674117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric cancer incidence among individuals with overgrowth syndromes and overgrowth features: A population-based assessment in seven million children.
    Connolly GK; Harris RD; Shumate C; Rednam SP; Canfield MA; Plon SE; Nguyen J; Schraw JM; Lupo PJ
    Cancer; 2024 Feb; 130(3):467-475. PubMed ID: 37788149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT Pelvis in Children; Should We Routinely Scan Pelvis for Wilms Tumor and Hepatoblastoma? Implications for Imaging Protocol Development.
    Mirza W; McHugh K; Aslam M; Sajjad Z; Abid W; Youssef T; Ali A; Fadoo Z
    J Coll Physicians Surg Pak; 2015 Oct; 25(10):768770-695. PubMed ID: 26454401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Counselor Practices Involving Pediatric Patients with FAP: an Investigation of their Self-Reported Strategies for Genetic Testing and Hepatoblastoma Screening.
    Lawson CE; Attard TM; Dai H; Septer S
    J Genet Couns; 2017 Jun; 26(3):586-593. PubMed ID: 27913912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?
    Aretz S; Koch A; Uhlhaas S; Friedl W; Propping P; von Schweinitz D; Pietsch T
    Pediatr Blood Cancer; 2006 Nov; 47(6):811-8. PubMed ID: 16317745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated hemihyperplasia in an infant: an overlooked sign for wilms tumor development.
    Mutafoglu K; Cecen E; Cakmakci H
    Iran J Pediatr; 2010 Mar; 20(1):113-7. PubMed ID: 23056692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice.
    Tan TY; Amor DJ
    J Paediatr Child Health; 2006 Sep; 42(9):486-90. PubMed ID: 16925531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging surveillance for children with predisposition to renal tumors.
    Srinivasan AS; Saade-Lemus S; Servaes SE; Acord MR; Reid JR; Anupindi SA; States LJ
    Pediatr Radiol; 2019 Oct; 49(11):1453-1462. PubMed ID: 31620846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal and neonatal hepatic tumors.
    Isaacs H
    J Pediatr Surg; 2007 Nov; 42(11):1797-803. PubMed ID: 18022426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of the tumor suppressor WTX in a subset of pediatric tumors.
    Akhavanfard S; Vargas SO; Han M; Nitta M; Chang CB; Le LP; Fazlollahi L; Nguyen Q; Ma Y; Cosper A; Dias-Santagata D; Han JY; Bergethon K; Borger DR; Ellisen LW; Pomeroy SL; Haber DA; Iafrate AJ; Rivera MN
    Genes Chromosomes Cancer; 2014 Jan; 53(1):67-77. PubMed ID: 24249259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.